Effect of daily chlorhexidine bathing on reducing infections caused by multidrug-resistant organisms in intensive care unit patients: A semiexperimental study with parallel controls
- PMID: 36779575
- DOI: 10.1111/jebm.12515
Effect of daily chlorhexidine bathing on reducing infections caused by multidrug-resistant organisms in intensive care unit patients: A semiexperimental study with parallel controls
Abstract
Objective: To assess the effectiveness of daily bathing by chlorhexidine bathing on multidrug-resistant organisms in ICU, especially on carbapenem-resistant Acinetobacter baumannii (CRAB), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Enterobacteriaceae (CRE).
Methods: Semiexperimental study which employed both precontrols and a parallel control was conducted. In the intervention period (from July 1 to December 31, 2016), strengthened infection control measures and daily bathing with 2% CHG-impregnated wipes once daily was performed in the ICU. Fifty-seven non-ICU wards with the occurrence of multidrug-resistant organisms (MDRO) infections during the same time were selected as parallel control group (only CHG bathing was not performed). The net effect of the 2% CHG daily bathing was evaluated by the difference in difference (DID) model.
Results: The DID model analysis showed that CHG bathing reduced the incidence of CRAB- and CRPA-caused infections in ICU by 1.56 and 2.15 cases/1000 patient days, and bathing of every 19 patients (95CI% 13 to 41) and 39 patients (95CI% 24 to 110) were able to prevent one case of HAIs of total MDROs and CRPA, respectively. However, CHG bathing showed no effect on MRSA, VRE, and CRE (p > 0.05).
Conclusion: Daily bathing with 2% CHG-impregnated wipes can reduce HAIs caused by CRAB and CRPA, while it is not effective for the prevalence of infections caused by MRSA, VRE, and CRE.
Keywords: 2% chlorhexidine gluconate; ICU; daily bathing; multidrug-resistant organisms.
© 2023 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.
Similar articles
-
A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.Infect Control Hosp Epidemiol. 2016 Jul;37(7):791-7. doi: 10.1017/ice.2016.23. Epub 2016 Feb 10. Infect Control Hosp Epidemiol. 2016. PMID: 26861417 Free PMC article. Clinical Trial.
-
Impact of universal contact precautions and chlorhexidine bathing on the acquisition of carbapenem-resistant enterobacterales in the intensive care unit: a cohort study.Antimicrob Resist Infect Control. 2024 Nov 22;13(1):139. doi: 10.1186/s13756-024-01495-1. Antimicrob Resist Infect Control. 2024. PMID: 39578838 Free PMC article.
-
Daily bathing strategies and cross-transmission of multidrug-resistant organisms: Impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit.Am J Infect Control. 2017 Oct 1;45(10):1069-1073. doi: 10.1016/j.ajic.2017.06.029. Epub 2017 Aug 10. Am J Infect Control. 2017. PMID: 28803661
-
Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.BMC Infect Dis. 2018 Dec 19;18(1):679. doi: 10.1186/s12879-018-3521-y. BMC Infect Dis. 2018. PMID: 30567493 Free PMC article. Review.
-
The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysis.BMC Infect Dis. 2019 May 14;19(1):416. doi: 10.1186/s12879-019-4002-7. BMC Infect Dis. 2019. PMID: 31088521 Free PMC article.
Cited by
-
Emergence of NDM-1- and OXA-23-Co-Producing Acinetobacter baumannii ST1 Isolates from a Burn Unit in Spain.Microorganisms. 2025 May 16;13(5):1149. doi: 10.3390/microorganisms13051149. Microorganisms. 2025. PMID: 40431320 Free PMC article.
References
REFERENCES
-
- Rello J, Eshwara VK, Lagunes L, et al. A global priority list of the Top Ten resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol. 2019;38(2), 319-323.
-
- Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3), 318-327.
-
- Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities. WHO Guidelines Approved by the Guidelines Review Committee. Geneva. 2017.
-
- Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory C. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10), S165-S193. Suppl 2.
-
- Tacconelli E, Mazzaferri F, de Smet AM, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect. 2019;25(7), 807-817.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources